Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings

Seeking AlphaDec 21 04:00

Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesDec 16 20:25 · Ratings

Watching Neumora Therapeutics; Shares See Volume To The Upside, Traders Circulate Unconfirmed Analyst Comments Saying "We Remain Buyers Into NMRA's MDD Data, Citing JNJ's Early Completion Of Phase III Aticaprant Study Efficacy And Safety Profile,...

BenzingaDec 7 03:38

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 3 01:35

Positive Outlook on Neumora Therapeutics Driven by Navacaprant's Potential in MDD Treatment

TipRanksNov 25 15:35

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

TipRanksNov 22 19:51 · Ratings